Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-12

Clinical Trial Update: Biodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET

View source ↗

Summary

A completed Johns Hopkins-sponsored study investigates biodistribution and pharmacokinetics of pretomanid in tuberculosis patients using 18F-labeled PET imaging…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pretomanid (pretomanid)

Snippet

Sponsor: Johns Hopkins University | Conditions: Tuberculosis | Status: COMPLETED